Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has issued an update.
JOINN Laboratories (China) Co., Ltd. announced a final cash dividend of RMB 0.03 per share for the year ending December 31, 2024, with payment scheduled for August 29, 2025. The dividend will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.0933, and the company will withhold a 10% tax for non-resident enterprise shareholders. This announcement may impact the company’s financial outlook and shareholder returns, highlighting its commitment to providing value to its investors.
The most recent analyst rating on (HK:6127) stock is a Buy with a HK$8.57 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. operates in the biotechnology and pharmaceutical industry, focusing on providing comprehensive research and development services. The company specializes in laboratory and preclinical services, catering to a wide range of clients in the pharmaceutical and biotech sectors.
Average Trading Volume: 7,230,263
Technical Sentiment Signal: Buy
Current Market Cap: HK$15.91B
See more data about 6127 stock on TipRanks’ Stock Analysis page.